APA (7th ed.) Citation

M, F., SD, S., J, K., L, W., R, R., D, L., . . . JD, G. (2024). CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy. The New England journal of medicine, 391(23), 2231. https://doi.org/10.1056/NEJMoa2412309

Chicago Style (17th ed.) Citation

M, Fontana, et al. "CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy." The New England Journal of Medicine 391, no. 23 (2024): 2231. https://doi.org/10.1056/NEJMoa2412309.

MLA (9th ed.) Citation

M, Fontana, et al. "CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy." The New England Journal of Medicine, vol. 391, no. 23, 2024, p. 2231, https://doi.org/10.1056/NEJMoa2412309.